A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With InhibitorMohammad Faranoush, Majid Naderi, N B Mirbehbahani et al.|Clinical and Applied Thrombosis/Hemostasis|2014Cited by 22
A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII DeficiencyMohammad Faranoush, Majid Naderi, Minoo Ahmadinejad et al.|Clinical and Applied Thrombosis/Hemostasis|2014Cited by 17
A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial.Gholamreza Toogeh, Shadi Sadat Alizadeh Fard, Mohammad Reza Ravanbod et al.|PubMed|2018Cited by 17